Show simple item record

dc.contributor.authorMiaris, N
dc.contributor.authorMaltezou, M
dc.contributor.authorPapaxoinis, Georgios
dc.contributor.authorVisvikis, A
dc.contributor.authorSamantas, E
dc.date.accessioned2016-10-27T15:32:52Z
dc.date.available2016-10-27T15:32:52Z
dc.date.issued2016-08-10
dc.identifier.citationPosterior reversible encephalopathy syndrome with concurrent nephrotic syndrome in a patient treated with pazopanib for metastatic renal cell carcinoma: case report and review of the literature. 2016, Clin Genitourin Canceren
dc.identifier.issn1938-0682
dc.identifier.pmid27601362
dc.identifier.doi10.1016/j.clgc.2016.08.005
dc.identifier.urihttp://hdl.handle.net/10541/619969
dc.languageENG
dc.language.isoenen
dc.rightsArchived with thanks to Clinical genitourinary canceren
dc.titlePosterior reversible encephalopathy syndrome with concurrent nephrotic syndrome in a patient treated with pazopanib for metastatic renal cell carcinoma: case report and review of the literature.en
dc.typeArticleen
dc.contributor.department3rd Department of Medical Oncology, 'Agii Anargiri' General Oncology Hospital of Kifissia, N. Kifissia, Athens, Greeceen
dc.identifier.journalClinical Genitourinary Canceren


Files in this item

This item appears in the following Collection(s)

Show simple item record